Salarius Pharmaceuticals, Inc. (DCOY)
NASDAQ · Healthcare
Salarius Pharmaceuticals, Inc. Shareholder Equity 2015–2022
Salarius Pharmaceuticals, Inc. annual shareholder equity history from 2015 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Salarius Pharmaceuticals, Inc. shareholder equity as of December 31, 2022: 10.4M, a 73.18% decrease year-over-year.
- Salarius Pharmaceuticals, Inc. shareholder equity for 2022 were 10.4M, a 73.18% decrease from 2021.
- Salarius Pharmaceuticals, Inc. shareholder equity for 2021 were 38.7M, a 74.75% increase from 2020.
- Salarius Pharmaceuticals, Inc. shareholder equity for 2020 were 22.2M, a 109.43% increase from 2019.
- Salarius Pharmaceuticals, Inc. shareholder equity for 2019 were 10.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Salarius Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $10 |
| 2021 | $39 |
| 2020 | $22 |
| 2019 | $11 |
| 2018 | $-1 |
| 2017 | $-3 |
| 2016 | $59 |
| 2015 | $92 |
Salarius Pharmaceuticals, Inc. Shareholder Equity — FAQ
Salarius Pharmaceuticals, Inc. (DCOY) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DCOY's shareholder equity history?
The chart and table above show Salarius Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.